Modeling Precision Interventions for Prostate Cancer Control
前列腺癌控制的精准干预建模
基本信息
- 批准号:10683180
- 负责人:
- 金额:$ 123.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-10 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAreaBahamasBehaviorBiological MarkersBiopsyBritish ColumbiaCalibrationCancer ControlCancer EtiologyCancer InterventionCancer Intervention and Surveillance Modeling NetworkCessation of lifeClinicalClinical SciencesClinical TrialsCountryDataData SetData SourcesDecision MakingDevelopmentDiagnosisDiagnosticDiseaseDisease modelEarly DiagnosisEventFred Hutchinson Cancer Research CenterFrustrationFunding OpportunitiesHormonalImageImaging DeviceImaging technologyIncidenceIndividualInternationalInterventionLeadLeadershipLearningLondonLong-Term EffectsMagnetic Resonance ImagingMalignant NeoplasmsMalignant neoplasm of prostateMethodologyMichiganModelingModernizationNatural HistoryNeoplasm MetastasisOutcomePSA screeningPatient CarePatient SelectionPatientsPolicePoliciesPopulationPopulation SciencesPositioning AttributePrecision therapeuticsProcessProstateProstate Cancer therapyRadical ProstatectomyRecording of previous eventsRecurrenceReduce health disparitiesResearch PersonnelResourcesRiskRisk EstimateRouteSalvage TherapySaudi ArabiaScreening for Prostate CancerSolidSolid NeoplasmSourceStatistical MethodsStratificationTechniquesTechnologyTestingTherapeuticTimeUnited KingdomUnited StatesUniversitiesUrologic OncologyValidationWorkadvanced diseaseblack mencancer diagnosiscollegecostcurative treatmentsdisease natural historydisorder riskearly screeningevidence basegenetic testinghigh risk menhigh risk populationimprovedindividual patientindividualized preventioninnovationinterdisciplinary approachmenmodels and simulationmortalitynovelnovel markerovertreatmentpersonalized carepersonalized interventionpersonalized medicinepersonalized screeningprocess optimizationprostate biopsyprostate cancer modelracial disparityrandomized trialrisk stratificationscreeningscreening policytreatment strategytrendworking group
项目摘要
PROJECT SUMMARY/ABSTRACT
Prostate cancer is the most common solid tumor in men and the second most common cause of cancer death
in the United States. The Cancer Intervention and Surveillance Modeling Network (CISNET) Prostate Working
Group (PWG) was formed in the year 2000 to address a wide range of questions about effective prostate
cancer control. The PWG studied the rapid increase in prostate cancer diagnoses after PSA screening started
in the late 1980s to estimate lead time and overdiagnosis associated with the test. The PWG studied the
decline in prostate cancer mortality that began in the early 1990s to quantify the plausible contributions of PSA
screening and changes in primary treatments. The PWG also studied how to interpret trends in racial
disparities in incidence and survival, how to manage men with low-risk disease on active surveillance, and how
to reconcile apparently discordant randomized trials of PSA screening and radical prostatectomy.
In recent years, technologies surrounding prostate cancer screening and treatment have evolved rapidly, and
opportunities to improve patient care using personalized data abound. Genetic testing can identify men at
increased risk for developing aggressive disease, new biomarkers and imaging tools can help men avoid
unnecessary biopsies, and new hormonal treatments can lengthen survival for men with advanced disease.
The objective of this application is to extend PWG models to evaluate optimal ways to utilize personalized data
to improve patient care while limiting harms and costs. We will determine whether we can improve early
detection using novel stratification approaches and whether we can safely limit overtreatment and other harms
by tailored choices of primary and secondary therapies. These approaches will be applied in the United States
and in international cancer control settings with different resources and priorities.
Our specific aims are as follows. Aim 1: Precision early detection, including risk-stratified screening and biopsy
using genetic tests, novel biomarkers, and imaging technology. Aim 2: Precision active surveillance, including
adaptive biopsy intervals and imaging technology. Aim 3: Precision treatment, including type and timing of
initial and salvage therapies. Aim 4: Targeting screening, biopsy, and treatment policies to reduce racial
disparities. Aim 5: Prioritizing screening and treatment interventions in international settings. These aims are
highly responsive to the funding opportunity announcement, addressing 7 of the 9 targeted priority areas to
varying degrees. Our cumulative expertise in prostate modeling, our existing models, and our close ties with
clinical experts who provide access to large, high-quality datasets for model validation and calibration put us in
a strong position to answer critical and impactful questions about how best to control this most common cancer
in men.
项目总结/摘要
前列腺癌是男性最常见的实体瘤,也是癌症死亡的第二大常见原因
在美国癌症干预和监测建模网络(CISNET)前列腺工作
PWG成立于2000年,旨在解决有关有效前列腺治疗的广泛问题。
癌症控制PWG研究了PSA筛查开始后前列腺癌诊断的快速增加
在20世纪80年代后期,估计与测试相关的前置时间和过度诊断。PWG研究了
20世纪90年代初开始的前列腺癌死亡率下降,以量化PSA的合理贡献
筛选和主要治疗的变化。PWG还研究了如何解释种族趋势,
发病率和生存率的差异,如何管理男性低风险疾病的积极监测,以及如何
协调PSA筛查和根治性前列腺切除术的明显不一致的随机试验。
近年来,前列腺癌筛查和治疗技术发展迅速,
利用个性化数据改善患者护理的机会比比皆是。基因检测可以识别男性,
发展侵袭性疾病的风险增加,新的生物标志物和成像工具可以帮助男性避免
不必要的活组织检查和新的激素治疗可以延长晚期疾病患者的生存时间。
这个应用程序的目的是扩展PWG模型,以评估利用个性化数据的最佳方法
改善病人护理,同时限制伤害和成本。我们将确定我们是否能及早改进
使用新的分层方法进行检测,以及我们是否可以安全地限制过度治疗和其他危害
通过量身定制的选择主要和次要治疗。这些方法将在美国应用
以及在资源和优先事项不同的国际癌症控制环境中。
我们的具体目标如下。目标1:精确的早期检测,包括风险分层筛查和活检
使用基因测试、新的生物标记和成像技术。目标2:精确主动监测,包括
自适应活检间隔和成像技术。目标3:精确治疗,包括治疗的类型和时机
初始和挽救治疗。目标4:有针对性的筛查,活检和治疗政策,以减少种族歧视
差距。目标5:在国际环境中优先进行筛查和治疗干预。这些目的是
高度响应筹资机会公告,解决9个目标优先领域中的7个,
不同程度的我们在前列腺建模方面积累的专业知识,我们现有的模型,以及我们与
临床专家为模型验证和校准提供大型高质量数据集,
一个强有力的立场,以回答关键和有影响力的问题,如何最好地控制这种最常见的癌症
在男人身上。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Editorial Comment.
编辑评论。
- DOI:10.1097/ju.0000000000001640.01
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Bauer,ScottR;Huang,Alison
- 通讯作者:Huang,Alison
Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.
- DOI:10.1007/s40273-022-01191-1
- 发表时间:2022-12
- 期刊:
- 影响因子:4.4
- 作者:Keeney, Edna;Sanghera, Sabina;Martin, Richard M.;Gulati, Roman;Wiklund, Fredrik;Walsh, Eleanor, I;Donovan, Jenny L.;Hamdy, Freddie;Neal, David E.;Lane, J. Athene;Turner, Emma L.;Thom, Howard;Clements, Mark S.
- 通讯作者:Clements, Mark S.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUTH D ETZIONI其他文献
RUTH D ETZIONI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUTH D ETZIONI', 18)}}的其他基金
Modeling Precision Interventions for Prostate Cancer Control
前列腺癌控制的精准干预建模
- 批准号:
10461832 - 财政年份:2020
- 资助金额:
$ 123.52万 - 项目类别:
Modeling Precision Interventions for Prostate Cancer Control
前列腺癌控制的精准干预建模
- 批准号:
10601453 - 财政年份:2020
- 资助金额:
$ 123.52万 - 项目类别:
Modeling Precision Interventions for Prostate Cancer Control
前列腺癌控制的精准干预建模
- 批准号:
10260543 - 财政年份:2020
- 资助金额:
$ 123.52万 - 项目类别:
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
建立模型以最大限度地减少癌症风险预测研究中的检测偏差
- 批准号:
10020923 - 财政年份:2019
- 资助金额:
$ 123.52万 - 项目类别:
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
建立模型以最大限度地减少癌症风险预测研究中的检测偏差
- 批准号:
10246991 - 财政年份:2019
- 资助金额:
$ 123.52万 - 项目类别:
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
建立模型以最大限度地减少癌症风险预测研究中的检测偏差
- 批准号:
10601444 - 财政年份:2019
- 资助金额:
$ 123.52万 - 项目类别:
Estimating Overdiagnosis in Cancer Screening Studies
评估癌症筛查研究中的过度诊断
- 批准号:
9267345 - 财政年份:2015
- 资助金额:
$ 123.52万 - 项目类别:
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations
改善不同人群前列腺癌预后的建模
- 批准号:
8969577 - 财政年份:2015
- 资助金额:
$ 123.52万 - 项目类别:
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations
改善不同人群前列腺癌预后的建模
- 批准号:
9332349 - 财政年份:2015
- 资助金额:
$ 123.52万 - 项目类别:
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations
改善不同人群前列腺癌预后的建模
- 批准号:
9132188 - 财政年份:2015
- 资助金额:
$ 123.52万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 123.52万 - 项目类别:
Fellowship Programs